Trials / Sponsors / Prof. Wolfgang Janni
Prof. Wolfgang Janni
Academic / Other · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy i Breast Cancer | Phase 3 | 2025-04-22 |
| Recruiting | Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer Breast Cancer | N/A | 2022-12-07 |
| Recruiting | Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced o Hormone Receptor-positive Metastatic Breast Cancer, HER2-negative Metastatic Breast Cancer | Phase 4 | 2022-04-27 |
| Active Not Recruiting | Detect V / CHEVENDO (Chemo vs. Endo) Metastatic Breast Cancer | Phase 3 | 2015-09-01 |
| Completed | DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circu HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal Female Patients | Phase 2 | 2014-01-01 |
| Completed | DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients HER2-negative Metastatic Breast Cancer, HER2-positive Circulating Tumor Cells | Phase 3 | 2012-02-01 |